Article Text
PDF
Abstract
Following publication of the original article [1], the authors reported an error in the typesetting of their article. The first section of the main text was mistakenly included in the abstract.
The original article can be found online at 10.1186/s40425-018-0465-0
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Statistics from Altmetric.com
The original article can be found online at 10.1186/s40425-018-0465-0
Correction to: Journal for ImmunoTherapy of Cancer (2018) 6:143
Doi: 10.1186/s40425-018-0465-0
Following publication of the original article [1], the authors reported an error in the typesetting of their article. The first section of the main text was mistakenly included in the abstract. This section begins with the sentence “Chemotherapy and immune-based therapies provide antitumor effects through completely different mechanisms” and ends with the following sentence:
“In exploring treatment duration with immune based therapies, we need to answer the following: (1) does indefinite treatment with immune based therapies exhaust the immune system counteracting its own mechanism of action leading to tumor progression and (2) how can clinical trials be designed to identify the optimal duration of immunebased therapy that prevents immune cell exhaustion but supports anti-tumor immunity.”
The published apologizes for any inconvenience caused by this error.